Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Haematologica
|
August 21, 2020
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infection
Francesca Tucci, Vera Gallo, Federica Barzaghi, et al.
Frontiers in Immunology
|
July 12, 2023
Hemophagocytic inflammatory syndrome in ADA-SCID: report of two cases and literature review
Elena Sophia Fratini, Maddalena Migliavacca, Federica Barzaghi, et al.
Frontiers in Immunology
|
December 17, 2020
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report
Sabina Cenciarelli, Valeria Calbi, Federica Barzaghi, et al.
Science Translational Medicine
|
May 1, 2024
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome
Giulia Consiglieri, Francesca Tucci, Maurizio De Pellegrin, et al.
Lancet (London, England)
|
January 23, 2022
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access
Francesca Fumagalli, Valeria Calbi, Maria Grazia Natali Sora, et al.
The New England Journal of Medicine
|
November 17, 2021
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome
Bernhard Gentner, Francesca Tucci, Stefania Galimberti, et al.
Nature Medicine
|
February 15, 2024
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency
Maddalena Migliavacca, Federica Barzaghi, Claudia Fossati, et al.
The New England Journal of Medicine
|
April 23, 2025
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy
Francesca Fumagalli, Valeria Calbi, Vera Gallo, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Haematologica
|
August 21, 2020
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infection
Francesca Tucci, Vera Gallo, Federica Barzaghi, et al.
Frontiers in Immunology
|
July 12, 2023
Hemophagocytic inflammatory syndrome in ADA-SCID: report of two cases and literature review
Elena Sophia Fratini, Maddalena Migliavacca, Federica Barzaghi, et al.
Frontiers in Immunology
|
December 17, 2020
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report
Sabina Cenciarelli, Valeria Calbi, Federica Barzaghi, et al.
Science Translational Medicine
|
May 1, 2024
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome
Giulia Consiglieri, Francesca Tucci, Maurizio De Pellegrin, et al.
Lancet (London, England)
|
January 23, 2022
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access
Francesca Fumagalli, Valeria Calbi, Maria Grazia Natali Sora, et al.
The New England Journal of Medicine
|
November 17, 2021
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome
Bernhard Gentner, Francesca Tucci, Stefania Galimberti, et al.
Nature Medicine
|
February 15, 2024
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency
Maddalena Migliavacca, Federica Barzaghi, Claudia Fossati, et al.
The New England Journal of Medicine
|
April 23, 2025
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy
Francesca Fumagalli, Valeria Calbi, Vera Gallo, et al.
Page
of 4